Core Viewpoint - The company, 嘉进投资国际 (00310), has announced a placement agreement to issue up to 250 million shares at a price of HKD 0.12 per share, representing a discount of approximately 16.67% from the last closing price of HKD 0.144 [1] Group 1: Placement Details - The placement will be conducted through a placement agent and is conditional upon certain terms [1] - The maximum number of shares to be placed represents about 28.7% of the company's enlarged issued share capital post-placement [1] - The estimated total gross proceeds from the placement are approximately HKD 30 million, with a net amount of about HKD 29 million expected [1] Group 2: Use of Proceeds - The net proceeds from the placement, estimated at HKD 29 million, are intended for investment acquisitions and general working capital of the group [1]

Core Viewpoint - The company, 嘉进投资国际 (00310), has announced a placement agreement to issue up to 250 million shares at a price of HKD 0.12 per share, representing a discount of approximately 16.67% from the last closing price of HKD 0.144 [1] Group 1: Placement Details - The placement will be conducted through a placement agent and is conditional, targeting at least six subscribers [1] - The 250 million shares represent about 28.7% of the company's enlarged issued share capital post-placement [1] - The estimated total gross proceeds from the placement are approximately HKD 30 million, with a net amount of around HKD 29 million expected [1] Group 2: Use of Proceeds - The net proceeds of HKD 29 million are intended for investment acquisitions and general working capital of the group [1]

Group 1 - The company, 嘉进投资国际 (00310.HK), has entered into a placement agreement with a placement agent to issue up to 250 million shares at a price of HKD 0.12 per share, which represents a discount of approximately 16.67% compared to the closing price of HKD 0.144 on the Hong Kong Stock Exchange [1] - The total estimated proceeds from the placement are approximately HKD 30 million, with a net amount of about HKD 29 million after deducting placement commissions and other related expenses [1] - The net proceeds of HKD 29 million are intended for investment acquisitions and general working capital of the group [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 PROSPERITY INVESTMENT HOLDINGS LIMITED హ 䙢 ᣅ 䋷 ഻ 䳋 ᴹ 䲀 ޜ ਨ * ˄ᯬⲮច䚄䁫ᡀ・ѻᴹ䲀ޜਨ˅ (㛑ԭԓ㲏˖00310) 於2026年2月10日（交易時段後），本公司與配售代理訂立配售協議，據此，本公司已有條件同 意透過配售代理按盡力基準以每股配售股份0.12港元之配售價向不少於六名承配人（其本身及 其實益擁有人須為獨立第三方）配售最多250,000,000股配售股份。 假設本公司已發行股本於本公告日期至配售完成日期期間並無任何變動，250,000,000股配售 股份相當於(i)本公告日期本公司現有已發行股本約40.2%；及(ii)經配發及發行250,000,000股 配售股份擴大後本公司已發行股本約28.7%。 配售價較(i)股份於最後交易日在聯交所所報收市價每股0.144港元折讓約16.67%；及(ii)股份於 最後交易日前最後五個連續交易日在聯 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或 因倚賴該等內容而引致之任何損失承擔任何責任。 PROSPERITY INVESTMENT HOLDINGS LIMITED హ 䙢 ᣅ 䋷 ഻ 䳋 ᴹ 䲀 ޜ ਨ * ˄ᯬⲮច䚄䁫ᡀ・ѻᴹ䲀ޜਨ˅ (㛑ԭԓ㲏˖00310) 更改根據特別授權配售新股份之所得款項用途 茲提述Prosperity Investment Holdings Limited嘉進投資國際有限公司（「本公司」，連同其附屬 公司統稱「本集團」）日期為2025年9月5日、2025年9月12日、2025年9月29日、2025年9月30日 及2025年10月14日之公告（「該等公告」），內容有關配售合共500,000,000股本公司普通股（「配 售事項」）以及所得款項淨額用途。 董事會謹此提供有關建議更改配售事項所得款項用途之最新資料。 配售事項之所得款項用途 於本公告日期之所得款項淨額動用情況分析及尚未動用所得款項淨額用途之經修訂變動載列 如下： | | | | | | 已更新悉數 | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 PROSPERITY INVESTMENT HOLDINGS LIMITED 嘉進投資國際有限公司（「本公司」）董事會宣佈自2026年2月20日起，本公司之香港股份過戶登 記分處將更改為：－ 卓佳證券登記有限公司 香港夏慤道16號 遠東金融中心17樓 電話：(852) 2980 1333 傳真：(852) 2810 8185 由2026年2月20日起，有關本公司之股份過戶及登記手續將由卓佳證券登記有限公司辦理。於 2026年2月19日下午四時三十分後仍未領取之股票，可於2026年2月20日起從卓佳證券登記有 限公司領取。 承董事會命 嘉進投資國際有限公司 公司秘書 林智深 香港，2026年2月6日 హ 䙢 ᣅ 䋷 ഻ 䳋 ᴹ 䲀 ޜ ਨ * ˄ᯬⲮច䚄䁫ᡀ・ѻᴹ䲀ޜਨ˅ (㛑ԭԓ㲏˖00310) 更改香港股份過戶登記處 於本公告日期，董事會由一名執行董事鄧子棟先生、一名非執行董事劉高原先生和四名獨立 非執 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 嘉進投資國際有限公司 呈交日期: 2026年2月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00310 | 說明 | 普通股 | | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.001 | HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.001 | HKD | | 100,00 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 原标题：300310宣布：10年前豪掷10亿元收购的子公司破产，财产已完成分配，公司仅分得83万元！此 前称收购时遭遇合同诈骗，已起诉 宜通世纪（维权）（SZ300310）斥资10亿元跨界并购过来的标的，如今走到了破产终结的结局，而宜 通世纪仅获得83万元的破产财产分配。 2月2日晚间，宜通世纪发布公告称，其曾经的全资子公司深圳市倍泰健康测量分析技术有限公司（以下 简称"倍泰健康"）破产程序终结。 这起曾被寄予厚望、旨在跨界智慧医疗的收购，最终演变为一场"噩梦"。从2018年倍泰健康"爆雷"开 始，宜通世纪不仅要因其业绩崩盘计提巨额商誉减值，还惹了一身的麻烦。 公司仅获83万元分配款 宜通世纪最新公告显示，公司近日收到广东省深圳市中级人民法院出具的《民事裁定书》，其债务人倍 泰健康被法院裁定终结破产程序。 公告显示，倍泰健康的破产清算申请于2023年11月13日被法院受理，倍泰健康于2026年1月26日被法院 裁定宣告破产。 据倍泰健康的《破产财产分配方案》，宜通世纪作为债权人，可获得分配的破产财产金额约83万元。宜 通世纪在公告中表示 ...

Core Viewpoint - Yitong Century's acquisition of Shenzhen Beitai Health Measurement and Analysis Technology Co., Ltd. for 1 billion yuan has ended in bankruptcy, resulting in the company receiving only 830,000 yuan from the bankruptcy distribution, highlighting the significant financial loss from the investment [1][2][3][4]. Group 1: Bankruptcy Proceedings - The bankruptcy proceedings for Beitai Health have been officially concluded, with the Shenzhen Intermediate People's Court issuing a civil ruling to terminate the bankruptcy process [3]. - Beitai Health's bankruptcy application was accepted on November 13, 2023, and it was declared bankrupt on January 26, 2026 [3]. - Yitong Century, as a creditor, is entitled to approximately 830,000 yuan from the bankruptcy distribution, which is expected to have a corresponding impact on the company's profits [3][4]. Group 2: Financial Impact and Historical Context - The acquisition price of 1 billion yuan for Beitai Health was significantly higher than its net assets of 173 million yuan at the time, resulting in over 800 million yuan in goodwill that later required substantial impairment [4]. - Yitong Century has already accounted for the impairment losses related to Beitai Health's overdue loans in previous years, indicating that the bankruptcy will not adversely affect the company's financial status further [4]. Group 3: Ongoing Legal Issues - Despite the conclusion of the bankruptcy proceedings, Yitong Century is still dealing with legal disputes related to the acquisition, including a lawsuit against Beitai Health's original shareholders for contract fraud [5]. - The case was sent back for retrial by the Guangdong High People's Court due to unclear facts in the initial judgment, and the outcome remains uncertain [5][6]. - Yitong Century's half-year report for 2025 indicated that it is pursuing the recovery of 770 million yuan from the original representative of Beitai Health, but there are concerns about the collectability of these funds due to the representative's financial difficulties [6].

Group 1 - The company, 嘉进投资国际 (00310), announced that its unaudited consolidated net asset value per share as of December 31, 2025, is approximately 0.028 HKD [1]